ArticlePediatrics international : official journal of the Japan Pediatric Society
Neurally adjusted ventilatory assist improves survival, and its early application accelerates weaning in preterm infants.
Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From theory to practice: implementing an education bundle for neurally adjusted ventilatory assist (NAVA) in the intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2026Article
- Application of neurally adjusted ventilatory assist (NAVA): a narrative review.Journal of thoracic disease · 2025Review
- Neurally adjusted ventilatory assist improves survival, and its early application accelerates weaning in preterm infants.Pediatrics international : official journal of the Japan Pediatric SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence to show that neurally adjusted ventilatory assist (NAVA) improves clinical outcomes is lacking. We aimed to analyze whether NAVA improves respiratory outcomes in preterm infants who require invasive mechanical ventilation.
methodsA retrospective cohort study was conducted in 122 very low birthweight infants who required invasive mechanical ventilation for more than 24 h at one tertiary neonatal intensive care unit in Korea from January 2016 to June 2023. Subjects were divided into three groups: early NAVA for those supported with NAVA before the seventh day of life (n = 18), late NAVA for those supported with NAVA later than the seventh day (n = 18), and conventional for those supported with conventional ventilation modes other than NAVA (n = 86).
resultsThere was no difference in the composite outcome of bronchopulmonary dysplasia or death among the three groups. Neonates who had been supported with NAVA at some point had lower odds of mortality than those who had not (adjusted odds ratio [aOR] 0.09, 95% CI 0.01-0.90, p = 0.040 for the early NAVA group; aOR 0.15, 95% CI 0.03-0.81, p = 0.027 for the late NAVA group). The adjusted hazard ratio for invasive mechanical ventilation weaning was higher in neonates supported with NAVA within the first week of life than in those supported with other ventilation modes (aHR 2.02, 95% CI 1.14-3.57, p = 0.015).
conclusionsNeurally adjusted ventilatory assist application was associated with lower odds of mortality, and its early application from the first few days of life helped preterm infants wean from invasive mechanical ventilation sooner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.